Clinical Trial Update: A Definitive Estrogen Patch Study (ADEPT) [Phase 2]

View source ↗

Summary

A phase 2 clinical trial (ADEPT) evaluating an estrogen patch for schizophrenia and related disorders has completed. Results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• Estrogen Patch (ADEPT) (estrogen patch)

Snippet

Sponsor: The Alfred | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 2 | Status: COMPLETED | Results posted: 2015-04-01